Use of benzodiazepine and risk of cancer: A meta‐analysis of observational studies

  title={Use of benzodiazepine and risk of cancer: A meta‐analysis of observational studies},
  author={Hong-Bae Kim and Seung Kwon Myung and Yon Chul Park and Byoungjin Park},
  journal={International Journal of Cancer},
Several observational epidemiological studies have reported inconsistent results on the association between the use of benzodiazepine and the risk of cancer. We investigated the association by using a meta‐analysis. We searched PubMed, EMBASE, and the bibliographies of relevant articles to locate additional publications in January 2016. Three evaluators independently reviewed and selected eligible studies based on predetermined selection criteria. Of 796 articles meeting our initial criteria, a… 

Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies

This meta-analysis revealed association between use of hypnotics drugs and risk of cancer, however, the use of lower dose hypnotics and shorter duration exposed to hypnotics seemed to be not associated with an increased risk ofcancer.

Benzodiazepine Use and Long-Term Mortality in South Korean Adult Population: A Cohort Study

Benzodiazepine use was associated with increased 5-year all-cause mortality in the South Korean adult population and further studies are needed to confirm these findings.

Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

An overview and interpretation on the current state of evidence regarding each of benzodiazepine and Z-drug associations is provided and what gaps in the evidence for drug-exposure–harm associations need to be addressed in the future are proposed.

Statin treatment and healthy adherer effects

The healthy adherer effect was first proposed in 1980, and many animal studies have demonstrated a consistent trend that statins were effective for osteoporosis, so the results of the RCTs could not be proved signally, so many observational studies were combined to prove the efficacy of statins for osteopsorosis.

Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting

This paper proposes the use of an integrated DME-DDD metric to obviate the limitations encountered when the component metrics are used in isolation, and enables superior interpretation of drug utilization results, especially for drug class summary reporting.

Benzodiazepine high‐doses: The need for an accurate definition

The aim of this review is to describe the different definitions used in the literature of high‐dose misuse and to test these definitions for their accuracy.

Evaluation of direct-to-patient educational approaches for reducing inappropriate sedative-hypnotic use in community-dwelling older adults

This thesis tests the hypothesis that older adults can enable the initiation of benzodiazepine deprescribing when equipped with evidence-based educational material about drug harms and safer non-pharmacological alternatives and addresses some of the observed barriers to sedative-hypnotic depresCribing.

Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer.

GABRD is upregulated in GC tissue and is associated with poor prognosis, suggesting that it may be a potential therapeutic target for GC.



Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

BZRD use was not associated with an overall increase in cancer risk, except for what is likely explained by minor lifestyle confounding, e.g. smoking.

Is Long-term Use of Benzodiazepine a Risk for Cancer?

The finding unveils benzodiazepines use into safe and unsafe groups for their carcinogenicity and could help physicians to select safer BZDs and provide an evidence on the carcinogenic effect of Benzodiazepine use by considering the LOE and DDD for further research.

Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan.

This population-based retrospective cohort study used data from 1996 to 2000 from the Taiwanese National Health Insurance system to investigate the possible association between benzodiazepine use and cancer risk and shed light on a possible relationship between Benzodiazepines use and increased cancer risk.

An association between benzodiazepine use and occurrence of benign brain tumors

Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States)

Data do not support an association between regular use of any of the drugs under study with ovarian cancer risk, and odds ratios for regular use were compatible with 1.0 for every drug class.

Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature

The prevalence of mood disorders reported in high-quality studies is generally lower than rates commonly reported in the general psychiatric literature, when controlled for common methodological confounds.

Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications

There is not an increased risk of ovarian cancer in women who have taken some types of antidepressants or benzodiazepines, according to the findings of a population-based case–control study.

Diazepam use in relation to breast cancer: results from two case-control studies.

The results of both studies suggest that regular diazepam use does not increase the risk of breast cancer and are strengthened by the similarity of the results using three different control groups--women with cancer, women with nonmalignant conditions, and neighbors.

Hypnotics' association with mortality or cancer: a matched cohort study

Receiving hypnotic prescriptions was associated with greater than threefold increased hazards of death even when prescribed <18 pills/year, and this association held in separate analyses for several commonly used hypnotics and for newer shorter-acting drugs.

Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States)

Data from two population-based case-control studies in the greater metropolitan Boston, MA (USA) were used to assess the association of self-reported use of antidepressants or benzodiazepine